隴神戎發(300534.SZ):取得換髮後藥品生產許可證
格隆匯8月13日丨隴神戎發(300534.SZ)公佈,公司因《藥品生產許可證》的企業負責人、質量負責人兼質量受權人申請變更,於2024年8月13日收到由甘肅省藥品監督管理局換髮變更後的《藥品生產許可證》。
本次換髮《藥品生產許可證》是基於公司日常經營管理實際,申請企業負責人由錢雙喜變更為宋月紅,質量負責人兼質量受權人由陳耀武變更為楊克謙,並依法完成變更手續。新證的取得確保了公司的正常生產經營,不會對公司經營業績產生重大影響,敬請廣大投資者理性投資、注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.